You have spent two weeks reading about six peptides getting a pass. Here is the part nobody says out loud for everyone on this list north of the border.
That policy is American.
HHS is a US federal department. The policy is written against section 503A of the US Food, Drug, and Cosmetic Act, and the pharmacies it describes are US state-licensed pharmacies. It is a decision about what one American agency will not enforce, against one American statute.
It does not rewrite anything in Canada.
So when you see a post saying BPC-157 is legal now, the honest footnote is: in the United States, through a prescription, from a pharmacy, one compound per vial. None of those four conditions describes a buyer up here.
Worth knowing, because the next few weeks are going to be loud. The comment window on that policy closes Friday, the AMA filed against it on November 6, and the coverage is not going to slow down. Almost none of it will be written with you in mind.
We are on your side of the border.
Keith
P.S. WELCOME30 takes 30% off a first order. And the hair research keeps coming up in the comments, so that is probably the next thing I write about.